Provide AI-powered biomarker discovery services for pharmaceutical companies and research institutions, using machine learning to identify novel diagnostic, prognostic, and predictive biomarkers from genomic, proteomic, and clinical data. This moonlite targets the growing precision medicine market where biomarkers are essential for drug development, patient stratification, and personalized treatment selection. Revenue streams include biomarker discovery consulting projects ($150,000-1,000,000 per study), clinical biomarker validation services ($75,000-500,000 per validation), AI-powered diagnostic test development ($200,000-1,500,000 per test), ongoing biomarker monitoring and analysis ($25,000-150,000 monthly per client), and licensing of validated biomarker panels to diagnostic companies ($500,000-5,000,000 per licensing agreement). Success requires advanced knowledge of molecular biology, genomics, and proteomics, expertise in bioinformatics and machine learning for biological data, understanding of clinical trial design and biomarker validation processes, familiarity with regulatory requirements for diagnostic tests, and ability to translate complex biological discoveries into clinically actionable diagnostic tools.
